What Is Tesamorelin?

Overview

Tesamorelin is a synthetic, stabilized analog of human growth-hormone-releasing hormone (GHRH). Rather than supplying growth hormone directly, it works one step upstream: it prompts the pituitary to secrete the body's own growth hormone in a pulsatile pattern. In research contexts it is most closely associated with studies of visceral adipose tissue and liver-fat metabolism, where its ability to raise endogenous growth hormone and downstream IGF-1 is the central variable of interest.

How Tesamorelin Works

The compound binds GHRH receptors on the somatotroph cells of the anterior pituitary, the same receptors targeted by native GHRH. Activation triggers the release of stored growth hormone, which in turn drives hepatic production of insulin-like growth factor-1 (IGF-1). Because the signal originates above the pituitary, the resulting secretion tends to preserve the natural pulsatile rhythm of the growth-hormone axis instead of flooding the system with a fixed exogenous dose. Structural modifications to the native GHRH sequence give Tesamorelin greater resistance to enzymatic degradation, extending its activity relative to unmodified GHRH fragments such as sermorelin.

What the Research Explores

• Reduction of visceral (deep abdominal) adipose tissue in metabolic models.
• Hepatic fat content and non-alcoholic fatty liver disease (NAFLD) pathways.
• Growth-hormone and IGF-1 axis dynamics under upstream stimulation.
• Glucose tolerance and other markers of metabolic function.

Forms & Handling

Tesamorelin is typically supplied as a lyophilized powder in research vials of 10 mg, 20 mg or 30 mg. It is reconstituted with bacteriostatic or sterile water for laboratory work; for example, a 10 mg vial taken up in 3.0 mL of bacteriostatic water yields roughly 3.33 mg/mL. The sealed powder is generally stored cold at 2–8 °C, sealed and protected from light, and the reconstituted solution is kept refrigerated. See the dosing protocols below for the reconstitution math expressed in insulin-syringe units.

Safety & Research Notes

Tesamorelin is handled here strictly as an investigational research compound. Because growth-hormone-axis stimulation can influence glucose handling, IGF-1 levels and fluid balance, the published literature pairs it with careful biochemical monitoring in controlled clinical settings. None of that translates into a safety profile for unsupervised use: there is no approved human or veterinary application in this context, and everything described above is mechanistic background rather than a usage recommendation.

References

Related Protocols